The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 05, 2025
Filed:
Feb. 02, 2022
Applicant:
Liminal Biosciences Limited, Cambridge, GB;
Inventors:
Shaun Abbott, Pointe Claire, CA;
Mylène De Léséleuc, Montreal, CA;
Julien Martel, Laval, CA;
Elyse Bourque, L'Étang-du-Nord, CA;
Jeremy Green, Waltham, MA (US);
Alexandre Larivée, Montreal, CA;
Jean-Benoǐt Giguère, Montreal, CA;
Elodie Landagaray, Montreal, CA;
Claudio Sturino, L'ile-Bizard, CA;
Assignee:
Liminal BioSciences Limited, Cambridge, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 405/12 (2006.01); C07D 213/69 (2006.01); C07D 319/12 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/06 (2006.01); C07D 405/06 (2006.01); C07D 405/14 (2006.01); C07D 407/12 (2006.01); C07D 409/14 (2006.01); C07D 413/06 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 491/052 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 405/12 (2013.01); C07D 213/69 (2013.01); C07D 319/12 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 405/06 (2013.01); C07D 405/14 (2013.01); C07D 407/12 (2013.01); C07D 409/14 (2013.01); C07D 413/06 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 491/052 (2013.01); C07D 498/04 (2013.01);
Abstract
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of GPR84, and the treatment of GPR84-mediated disorders.